Cargando…
Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target
SIMPLE SUMMARY: Nasopharyngeal carcinoma is distinguished from other head and neck carcinomas by the association of its carcinogenesis with the Epstein–Barr virus. It is highly metastatic, and a novel therapeutic modality for metastatic nasopharyngeal carcinoma is keenly awaited. Protein farnesylati...
Autores principales: | Kobayashi, Eiji, Kondo, Satoru, Dochi, Hirotomo, Moriyama-Kita, Makiko, Hirai, Nobuyuki, Komori, Takeshi, Ueno, Takayoshi, Nakanishi, Yosuke, Hatano, Miyako, Endo, Kazuhira, Sugimoto, Hisashi, Wakisaka, Naohiro, Yoshizaki, Tomokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220992/ https://www.ncbi.nlm.nih.gov/pubmed/35740492 http://dx.doi.org/10.3390/cancers14122826 |
Ejemplares similares
-
Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021) -
EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non‐endemic region
por: Kondo, Satoru, et al.
Publicado: (2022) -
Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018) -
Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma
por: Hirai, Nobuyuki, et al.
Publicado: (2016) -
Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
por: Nakanishi, Yosuke, et al.
Publicado: (2017)